Avalyn Pharma Inc. Common Stock
NASDAQ:AVLNMedical - Pharmaceuticals
Healthcare
$27.69 +1.77%
+$0.52 today
- Market cap
- $1.23B
- Beta
- 0.00
52W Low $24.15High $32.23
Volume 0.40M
Average 0.51M
Income Statement
Follow revenue through to earnings.
Revenue
—
Operating Income
—
Net Income
—
Income Statement
Currency unavailable
AVLN Earnings Waterfall · TTM
NASDAQ:AVLN · Revenue to Net Income
No earnings data available.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 8-K | Current report | Nov 12, 2026 | |
| 4 | Statement of changes in beneficial ownership | Nov 12, 2026 | |
| 10-Q | Quarterly report | Nov 12, 2026 | |
| 4 | Statement of changes in beneficial ownership | Sep 17, 2026 | |
| 3 | Initial statement of beneficial ownership | Sep 17, 2026 |
Continue the stock analysis
Jump to another research area for this company.